Ardelyx Inc.

Ardelyx Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
62.05 M
Public Float
33.22 M
Ardelyx Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.68
Market Cap
$169.02 M
Shares Outstanding
62.6 M
Public Float
43.82 M

Profile

Address
34175 Ardenwood Boulevard
Fremont California 94555
United States
Employees -
Website http://www.ardelyx.com
Updated 07/08/2019
Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicine for the treatment of renal diseases. It also focuses on the development of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development.

Financials

View All

Michael G. Raab
President, Chief Executive Officer & Director
Dave M. Mott
Chairman